GST rejig may impact competitiveness of medical devices: AiMeD
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
Guidelines aim to establish state-regulated veterinary blood banks
This project shall be implemented through incorporation of a new joint venture company in Zambia
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Subscribe To Our Newsletter & Stay Updated